Skip to content

Proto Labs PRLB Free cash flow

Free cash flow at other companies

Xometry, Inc. logo
Xometry, Inc.XMTR
-$5.86M
Standex International logo
Standex InternationalSXI
$6.16M+77.5%
OTT
Otter TailOTTR
-$114.67M-518%
Kennametal logo
KennametalKMT
$42.41M+18.0%
Benchmark Electronics logo
Benchmark ElectronicsBHE
$31.01M+10.3%
Barnes Group logo
Barnes GroupB
$34.73M+173%

Other financials

Income statement

See full
Revenue$139.3M+10.4%
Gross profit$63.6M+14.2%
Operating income$9.8M+117%
Net income$8.1M+125%
EPS (diluted)$0.33+120%

Balance sheet

See full
Cash & equivalents$124.0M+49.9%
Total debt$2.6M-16.6%
Total equity$683.1M+4.0%
Total assets$778.6M+5.6%

Cash flow

See full
Operating cash flow$17.5M-4.6%
CapEx$3.5M+181%

Valuation

See full
Market cap$1.9B+59.7%
Enterprise value$1.78B+60.4%
P/E73.7×-3.9×
P/S3.5×+1.1×

Profitability

See full
Gross margin44.9%+0.5pp
Operating margin5.6%+1.7pp
Net margin4.7%+1.6pp
FCF margin10.4%-3.1pp

Returns & leverage

See full
Return on equity3.8%+1.6pp
Debt / equity0.0×
Current ratio3.5×+0.4×

Where this comes from

Calculated from Proto Labs’s reported figures.

The official record: Proto Labs’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Proto Labs's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Proto Labs's free cash flow?
Proto Labs (PRLB) reported free cash flow of $14M in Q1 2026.
How has Proto Labs's free cash flow changed year-over-year?
Proto Labs's free cash flow decreased by 18.2% year-over-year, from $17.12M to $14M.
What is the long-term trend for Proto Labs's free cash flow?
Over 4 years (2021 to 2025), Proto Labs's free cash flow has grown at a 29.8% compound annual growth rate (CAGR), from $21.03M to $59.66M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.